Using our mobile app? Be sure to check for any new app updates to receive any enhancements.
Logo

Get Healthy!

Results for search "Research &, Development".

Health News Results - 313

The future of COVID-19 treatments might include a tiny antibody made by llamas.

British researchers credit a llama named Fifi with their finding.

The investigators said these llama nanobodies, which are also produced by camels, could eventually be produced in a lab and administered by a nasal spray, binding tightly to the COVID-19 virus and neutralizing it.

The potential solu...

Movement can be very difficult for people with Parkinson's disease, as shaking and stiffness play havoc with balance, coordination and gait.

There are many different tricks Parkinson's patients can use to improve their walking and avoid injury from a bad tumble -- but a new study reveals that people often have to figure them out on their own, with no help from either a doctor or physical ...

The "white cane" that many blind people rely on for navigating the world hasn't been upgraded in a century, but researchers are reporting progress on a "robo-cane" they hope will modernize the assistive device.

The prototype cane is equipped with a color 3D camera, sensors and an "on-board" computer designed to guide the user to a desired location and avoid any obstacles alon...

The heart rates of people sync up when listening to a story, a new study finds.

"There's a lot of literature demonstrating that people synchronize their physiology with each other. But the premise is that somehow you're interacting and physically present [in] the same place," said co-author Lucas Parra, a professor of biomedical engineering at City College of New York.

"What we hav...

TUESDAY, Sept. 14, 2021 (HealthDay News) – New data out of Israel, to be published this week, could bolster the notion that a third booster shot of the COVID-19 vaccine significantly lowers a recipient's odds for severe illness.

The data is scheduled to be published in the peer-reviewed New England Journal of Medicine, ahead of this week's U.S. Food and Drug Administra...

Many people with asthma know their illness can flare up at night, and new research suggests the body's internal clock could be to blame.

The findings could prove important for treating and studying asthma, the researchers said.

"This is one of the first studies to carefully isolate the influence of the circadian system from the other factors that are behavioral and environmental, in...

A first-of-a-kind nerve stimulation treatment for people who have problems moving their arms after a stroke has been approved by the U.S. Food and Drug Administration.

"People who have lost mobility in their hands and arms due to ischemic stroke are often limited in their treatment options for regaining motor function," explained Dr. Christopher Loftus. He is acting director of the FDA's ...

Early treatment with COVID-19 survivors' blood plasma doesn't prevent disease progression in people who have mild COVID-19 symptoms but are at risk for more severe illness, a new clinical trial finds.

"As physicians, we wanted this to make a big difference in reducing severe illness and it did not," said principal investigator Dr. Clifton Callaway, professor of emergency medicine at the U...

Antibodies generated by COVID-19 vaccines are effective against the Delta variant and other coronavirus variants of concern, new research shows.

The findings may help explain why most vaccinated people have avoided the surge of Delta variant cases sweeping across the United States.

"In face of...

A new pill specifically designed to prevent migraines appears to do the job, a new clinical trial finds.

Atogepant cut patients' migraine days in half over 12 weeks of treatment, without causing serious side effects, the researchers said.

Experts said the drug, if approved by the U.S. Food and Drug Administration, would give migraine sufferers a welcome new option.

"There's a ...

There's strong evidence that the steroid drug dexamethasone can significantly lower hospitalized patients' risk of dying from COVID-19, but many who might benefit from it the most aren't getting it.

"Dexamethasone is a steroid that is used for the treatment of arthritis, inflammation and allergic reactions," explained Hemalkumar Mehta, who studied its use in treating COVID-19 patients. He...

Twenty seconds.

That's how long you need to wash your hands to remove germs, a new physics study confirms.

Typical hand-washing guidelines -- including those from the U.S. Centers for Disease Control and Prevention -- advise scrubbing your hands for a minimum of 20 seconds.

To assess that recommendation, researchers used a mathematical model to examine the key mechanics of h...

When the antiretroviral regimen known as pre-exposure prophylaxis, or PrEP, was launched nearly a decade ago, patients were suddenly able to achieve near-complete protection against contracting HIV by taking just one pill a day.

But there's a big hitch: Not everyone is equally diligent about sticking to that once-a-day daily pill regimen, and when doses are missed PrEP's protective shield...

Schizophrenia is a debilitating disease that can make navigating daily life a massive challenge, but a new blood test could flag it in its early stages, researchers say.

Their analysis of blood samples identified epigenetic markers -- part of your DNA -- that differ between people with schizophrenia and those without the mental health disorder.

The researchers developed a model to a...

Barnacles may be the bane of ships, but they could point to new ways to quickly halt severe bleeding, researchers report.

Barnacles are small crustaceans that attach to rocks, ship hulls and even other animals, such as whales. Their ability to cling to surfaces that are often wet and dirty caught the attention of researchers trying to find new ways to seal wounds in emergency situations.<...

An experimental gel has shown early promise in treating the most common form of skin cancer -- hinting at a potential alternative to surgery in the future.

Researchers tested the gel in 30 patients with basal cell carcinoma (BCC), a skin cancer diagnosed in more than 3 million Americans each year. The tumors rarely spread and are highly curable, usually through surgical removal.

Eve...

In a first, researchers have used genetically tweaked immune system cells to send a woman's severe lupus into remission.

The treatment -- called CAR T-cell therapy -- is already approved in the United States for fighting certain cases of blood cancer. It involves removing a patient's own immune system T-cells, genetically altering them to target the cancer, then infusing them back into th...

Could a drug used to treat amyotrophic lateral sclerosis (ALS) help people with mild Alzheimer's disease?

The results of a small new study suggest the strategy could work.

Riluzole has been used for more than 20 years to slow the progression of ALS, commonly called Lou Gehrig's disease. This phase 2 study found that the drug slowed brain metabolic decline and had a positive effect o...

Dogs may be man's best friend, but cats may hold critical keys to humans' health.

Our feline friends have the potential to become a valuable model for genetic research, because their genome is similar to that of people, according to Leslie Lyons of the Feline Genetics Laboratory at the University of Missouri in Columbia.

"Using cats in research is really overlooked, since people don...

Trusting science is good, but it could put you at risk for being duped by false science, or "pseudoscience," if you let your guard down, researchers warn.

Investigators found that people who trust science are more likely to believe and share false claims that contain scientific references than those who don't trust science.

"We conclude that trust in science, although desirable in m...

While efforts to develop Alzheimer's medications have so far borne little fruit, new research highlights the therapeutic promise of two non-drug tools: light and sound.

According to a pair of small new studies, exposing Alzheimer's patients to an hour a day of carefully modulated light and/or sound appears, over time, to slow down the telltale brain degeneration that typifies disease prog...

Children with autism differ socially and developmentally from their typically developing peers. Now, researchers say there are also differences in their array of healthy gut bacteria or "microbiome."

The findings may lead to earlier treatment for kids with an autism spectrum disorder, suggested the authors of a new small study.

The gut microbiome can vary according to where people l...

A drug that eases hallucinations in people with Parkinson's disease may be able to do the same for those with dementia, a new clinical trial finds.

The medication, called Nuplazid (pimavanserin), is already approved in the United States for treating hallucinations and delusions related to Parkinson's.

The new study, published July 22 in the New England Journal of Medicine, ...

A Chinese researcher has died after catching a rare infectious disease called the Monkey B virus, Chinese Center for Disease Control and Prevention officials say.

In March, the 53-year-old veterinarian dissected two dead monkeys as part of his work in a Beijing research institute specializing in nonhuman primate breeding. He developed nausea, vomiting and fever a month later, and died May...

The causes of a type of excruciating headache known as cluster headaches aren't clear, but heredity is known to play a role. Now, genetic factors associated with cluster headaches are under investigation as scientists search for more effective treatments.

Researchers at the Karolinska Institute in Sweden analyzed blood samples from more than 600 people with cluster heada...

Glaucoma is a leading cause of vision loss in older people, and early detection can bring better treatment. Now, researchers in Australia say their experimental genetic test for glaucoma can identify 15 times more people at high risk for the disease compared to a current genetic test.

"Early diagnosis of glaucoma can lead to vision-saving treatment, and genetic information can potentiall...

Researchers have developed an implant that allowed a man with severe paralysis to "speak" again by translating his brain signals into text.

The achievement is the latest step in "brain-computer interface" (BCI) research.

Scientists have been studying BCI technology for years, with the aim of one day giving people with paralysis or limb amputations greater independence in their daily...

Breathing in protection: Scientists say an experimental inhaled COVID-19 vaccine shows promise in animal tests.

"The currently available vaccines against COVID-19 are very successful, but the majority of the world's population is still unvaccinated and there is a critical need for more vaccines that are easy to use and effective at stopping disease and transmission," said study co-leader ...

Why do some people infected with SARS-CoV-2 have either no or negligible symptoms, while others sicken and die?

Scientists who've pinpointed several genetic markers associated with severe COVID-19 say their findings could provide answers to that important question -- and targets for future treatments.

The investigators spotted 13 locations in human DNA that are strongly associated w...

Researchers have identified specific brain circuitry that is related to people's sense of spirituality -- and it's centered in a brain region linked to pain inhibition, altruism and unconditional love.

The findings add to research seeking to understand the biological basis for human spirituality.

"It is something of a treacherous subject to navigate," said lead researcher Michael Fe...

An experimental drug can prevent intestinal damage caused by celiac disease, an early trial has found -- raising hopes that it could become the first medication for the serious digestive disorder.

With celiac disease, the immune system attacks the lining of the small intestine when a genetically susceptible person eats gluten -- a protein found in wheat, rye and barley.

The symptoms...

You have type 2 diabetes, and you are already taking an old standby drug, metformin. But you still need help controlling your blood sugar levels. Which medication would be the best?

New research pitted several diabetes drugs against each other and came up with an answer: The diabetes drugs Lantus and Victoza were better at controlling blood sugar over time than Amaryl or Januvia.

"W...

Early research suggests that CRISPR gene-editing technology may some day lead to dramatic relief for patients struggling with amyloidosis, a rare but serious disease that can trigger organ failure.

"There are many different types of amyloidosis," explained study author Dr. Julian Gillmore, a researcher in medicine with the Centre for Amyloidosis and Acute Phase Proteins at University Coll...

Researchers are reporting early success with a temporary heart pacemaker that simply dissolves when it's no longer needed.

So far the work has been limited to animals and human heart tissue studied in the lab. But experts said the early findings are "exciting" and could eventually change the care of patients who need a pacemaker for only days to weeks.

Pacemakers are devices that ar...

Could trees be the key to a cool summer in the city?

Yes, claims new research that calculated just how much greenery can bring temperatures down.

"We've long known that the shade of trees and buildings can provide cooling," said study co-author Jean-Michel Guldmann. He is a professor emeritus of city and regional planning at Ohio State University, in Columbus.

"But now we can...

FRIDAY, June 25, 2021 (Healthday News) -- Fresh on the heels of the U.S. Food and Drug Administration's approval of the controversial Alzheimer's drug Aduhelm, the maker of a second medicine that works in similar fashion said Thursday it hopes to apply for approval of its medication later this year.

Eli Lilly said findings from a mid-stage clinical trial of 272 patients with early Alzheim...

The first case of COVID-19 may have occurred in China weeks earlier than previously thought, a new study claims.

The first officially identified case occurred in early December 2019, but increasing evidence suggests the original case may have emerged earlier.

In this study, British researchers conducted a new analysis and concluded that the first case of COVID-19 arose between early...

Pollen is tough enough for allergy sufferers, but a new study suggests it also helps spread the new coronavirus and other airborne germs.

Researchers had noticed a connection between COVID-19 infection rates and pollen concentrations on the National Allergy Map of the United States.

That led them to create a computer model of all the pollen-producing parts of a willow tree. They the...

It's been more than six months since Brandy Compton last landed in a hospital emergency room.

That's an amazing medical achievement, brought about by scientific breakthroughs that have been unfortunately overshadowed by the coronavirus pandemic, experts say.

Compton, 31, was born with sickle cell disease, a genetic condition that primarily affects people of African descent.

T...

Aiming to deliver a one-two punch to the herpes virus, animal research on an experimental drug found it tackled active infections and reduced or eliminated the risk of future outbreaks.

Existing treatments, such as Zovirax, Valtrex or Famvir, are only effective at the first task; they can help treat cold sores and genital eruptions once a herpes outbreak occurs. But the new ...

The vast majority of editors at leading medical journals are white - with few of those influential spots going to Black or Hispanic professionals, a new study finds.

The study comes on the heels of a controversy that prompted the resignation of the editor-in-chief of the Journal of the American Medical Association.

It all started in February when Dr. Ed Livingston, a JA...

Researchers are using mice to study a potential new treatment that could help patients who have sickle cell disease, without some of the risks and side effects of existing therapies.

The investigators reported using genetic-based editing on mice to convert a disease-causing hemoglobin gene to a benign variant that would enable healthy blood cell production.

Sickle cell disease (SCD...

The first drug ever shown to slow the progression of Alzheimer's disease could be approved by the U.S. Food and Drug Administration on Monday, but experts say that approval will be surrounded by controversy.

In clinical trials, aducanumab showed a 22% reduction in the development of thinking and memory problems associated with Alzheimer's disease, according to a statement from the Alzheim...

Reacting to recent controversy, the American Medical Association (AMA) announced Thursday a series of steps it will take to promote diversity, equity and inclusion within the medical society and its network of 12 influential journals.

Dr. Howard Bauchner, editor-in-chief of the Journal of the American Medical Association (JAMA), is stepping down at the end of June, forced out ov...

The U.S. government and nonprofits are replacing drug companies as the main drivers of Alzheimer's disease research, two new studies show.

The findings are from an analysis of national data by Jeffrey Cummings, a research professor at the University of Nevada, Las Vegas School of Integrated Health Sciences.

In one study, his team found that the number of Alzheimer's clinical trials ...

People with spinal cord injuries can overwork their shoulders as they move about in a wheelchair, and that often leads to chronic shoulder pain.

However, a small study suggests that an injection of the patient's own fat cells can help ease the pain.

The injected cells cushion the joint and may repair it, the researchers explained. Most important, they said that the procedure - calle...

Moderna's coronavirus vaccine fully protects children aged 12 to 17, the company announced Tuesday.

In a clinical trial that included more than 3,700 young volunteers, there were no cases of symptomatic COVID-19 infection in the two-thirds of participants who received both doses of the vaccine, which translates into an efficacy rate of 100%.

That's the same rate that was reported re...

Doctors for the first time have used a form of gene therapy to restore partial vision in a blind person, according to findings announced Monday.

The research team genetically altered retinal ganglion cells to become light-sensitive in a man whose vision was destroyed by retinitis pigmentosa, a genetic disorder that breaks down cells that absorb and convert light into brain signals.

...

Studies that can't be verified and may be untrue are much more likely to be cited in the media because they tend to be more interesting, researchers report.

They looked at studies in top psychology, economic and nature/science journals and found that only 39% of 100 psychology papers were successfully replicated. The replication rates were 61% for 18 economic studies, and 62% amo...

If you've ever wished you had an extra hand to accomplish a task, never fear, scientists are working on that. But a new study raises questions about how such technology could affect your brain.

The findings come from ongoing research into a 3D-printed robotic thumb known as "Third Thumb." It's worn on a person's dominant hand, making it capable of feats that normally demand both hands.